Abbreviated Name

Prostate Rapid Ref Set App: Getzenberg (2006)

Lead Investigator

Getzenberg, Robert H. — Johns Hopkins University

Coordinating Investigator

Zheng, Yingye — Fred Hutchinson Cancer Center

Involved Investigators

• Srivastava, Sudhir — National Cancer Institute
• Zheng, Yingye — Fred Hutchinson Cancer Center
• Getzenberg, Robert H. — Johns Hopkins University

Abstract

Analyze marker EPCA2 on 123 observations (60 prostate cancers and 63 non-prostate cancers)

Aims

Analyze marker EPCA2 on 123 observations (60 prostate cancers and 63 non-prostate cancers)

Analytic Method

Analyzed by the DMCC

Comments

No comments available.

Outcome

A blinded study coordinated by the EDRN GU Collaborative Group found the biomarker is not associated with prostate cancer risk

Secure Outcome

No secure outcome available.

Publications

• No publications available at this time for this protocol.

Biomarkers

• EPCA-2

Data Collections

• No data collections available at this time for this protocol.

 Team Project

Start Date

Feb 1 2006

Estimated Finish Date

Feb 1 2007

Finish Date

Jun 1 2009

Protocol ID

292

Protocol Type

Reference Set

Fields of Research

• Proteomics

Collaborative Group

Prostate and Urologic Cancers Research Group

Cancer Types

• Malignant neoplasm of prostate

Phased Status

1